Amniotic Fluid Infection in Preterm Pregnancies with Intact Membranes

Disease Markers

Volumn 2017, Issue , 2017, Pages

  Myntti, Tarja ^a   Rahkonen, Leena ^a   Nupponen, Irmeli ^b   Pätäri Sampo, Anu ^c   Tikkanen, Minna ^a   Sorsa, Timo ^a,d   Juhila, Juuso ^e   Andersson, Sture ^b   Paavonen, Jorma ^a   Stefanovic, Vedran ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d KAROLINSKA INSTITUTE   (Sweden)

^e Medix Biochemica   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GELATINASE A; GELATINASE B; INTERLEUKIN 6; LEUKOCYTE ELASTASE; MYELOPEROXIDASE; NEUTROPHIL COLLAGENASE; TIPRELESTAT; TISSUE INHIBITOR OF METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE; PEROXIDASE;

ADULT; AMNIOCENTESIS; AMNION; AMNIONITIS; AMNIOTIC FLUID INFECTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOENZYMOMETRIC ASSAY; PREGNANCY OUTCOME; PREMATURE LABOR; AMNION FLUID; CASE CONTROL STUDY; ENZYMOLOGY; METABOLISM; MICROBIOLOGY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREMATURE BIRTH; PROTEIN DEGRADATION;

ADULT; AMNIOTIC FLUID; BIOMARKERS; CASE-CONTROL STUDIES; ELAFIN; FEMALE; HUMANS; INTERLEUKIN-6; LEUKOCYTE ELASTASE; MATRIX METALLOPROTEINASES; PEROXIDASE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREMATURE BIRTH; PROTEOLYSIS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 85010408661     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2017/8167276     Document Type: Article

References (39)

1. C. J. Kim, R. Romero, P. Chaemsaithong, N. Chaiyasit, B. H. Yoon, Y. M. Kim, "Acute chorioamnionitis, funisitis: definition, pathologic features, clinical significance, "American Journal ofObstetrics andGynecology, vol. 213, no. 4, pp. S29-S52, 2015.
2. S. L. Hillier, S. S. Witkin, M. A. Krohn, D. H. Watts, N. B. Kiviat, D. A. Eschenbach, "The relationship of amniotic fluid cytokines, preterm delivery, amniotic fluid infection, histologic chorioamnionitis, chorioamnion infection, " Obstetrics, Gynecology, vol. 81, no. 6, pp. 941-948, 1993.
3. R. Romero, J. Miranda, T. Chaiworapongsa, et al., "Prevalence, clinical significance of sterile intra-amniotic inflammation in patients with preterm labor, intact membranes, " American Journal of Reproductive Immunology, vol. 72, no. 5, pp. 458-474, 2014.
4. H. Alfakry, E. Malle, C. N. Koyani, P. J. Pussinen, T. Sorsa, "Neutrophil proteolytic activation cascades: a possible mechanistic link between chronic periodontitis, coronary heart disease, " Innate Immunity, vol. 22, no. 1, pp. 85-99, 2016.
5. C. W. Park, B. H. Yoon, S. M. Kim, J. S. Park, J. K. Jun, "The frequency, clinical significance of intra-amniotic inflammation defined as an elevated amniotic fluid matrix metalloproteinase-8 in patients with preterm labor, low amniotic fluid white blood cell counts, " Obstetricsand Gynecology Science, vol. 56, no. 3, pp. 167-175, 2013.
6. K. J. Oh, S. E. Lee, H. Jung, G. Kim, R. Romero, B. H. Yoon, "Detection of ureaplasmas by the polymerase chain reaction in the amniotic fluid of patients with cervical insufficiency, " Journal of Perinatal Medicine, vol. 38, no. 3, pp. 261-268, 2010.
7. E. Maymon, R. Romero, P. Pacora, et al., "Human neutrophil collagenase (matrix metalloproteinase 8) in parturition, premature rupture of the membranes, intrauterine infection, " American Journal of Obstetrics, Gynecology, vol. 183, no. 1, pp. 94-99, 2000.
8. J. K. Nien, B. H. Yoon, J. Espinoza, et al., "ArapidMMP-8 bedside test for the detection of intra-amniotic inflammation identifies patients at risk for imminent preterm delivery, " American Journal of Obstetrics, Gynecology, vol. 195, no. 4, pp. 1025-1030, 2006.
9. S. E. Lee, R. Romero, S. M. Lee, B. H. Yoon, "Amniotic fluid volume in intra-amniotic inflammation with, without culture-proven amniotic fluid infection in preterm premature rupture of membranes, " Journal of Perinatal Medicine, vol. 38, no. 1, pp. 39-44, 2010.
10. S. M. Kim, R. Romero, J. Lee, et al., "About one-half of early spontaneous preterm deliveries can be identified by a rapid matrix metalloproteinase-8 (MMP-8) bedside test at the time of mid-trimester genetic amniocentesis, " Journal ofMaternal-Fetal, Neonatal Medicine, vol. 29, no. 15, pp. 2414-2421, 2016.
11. S. M. Kim, R. Romero, J. W. Park, K. J. Oh, J. K. Jun, B. H. Yoon, "The relationship between the intensity of intra-amniotic inflammation, the presence, severity of acute histologic chorioamnionitis in preterm gestation, " Journal of Maternal-Fetal, Neonatal Medicine, vol. 28, no. 13, pp. 1500-1509, 2015.
12. E. Maymon, R. Romero, T. Chaiworapongsa, et al., "Amniotic fluid matrix metalloproteinase-8 in preterm labor with intact membranes, " American Journal of Obstetrics, Gynecology, vol. 185, no. 5, pp. 1149-1155, 2001.
13. J. Lee, K. J. Oh, H. J. Yang, J. S. Park, R. Romero, B. H. Yoon, "The importance of intra-amniotic inflammation in the subsequent development of atypical chronic lung disease, " Journal ofMaternal-Fetal, NeonatalMedicine, vol. 22, no. 10, pp. 917-923, 2009.
14. A. E. King, R. W. Kelly, J.-M. Sallenave, A. D. Bocking, J. R. G. Challis, "Innate immune defences in the human uterus during pregnancy, " Placenta, vol. 28, no. 11-12, pp. 1099-1106, 2007.
15. T. Myntti, L. Rahkonen, M. Tikkanen, A. Pätäri-Sampo, J. Paavonen, V. Stefanovic, "Amniotic fluid rapid biomarkers are associated with intra-amniotic infection in preterm pregnancies regardless of the membrane status, " Journal of Perinatology, vol. 36, no. 8, pp. 606-611, 2016.
16. C. A. Combs, M. Gravett, T. J. Garite, et al., "Amniotic fluid infection, inflammation, colonization in preterm labor with intact membranes, " American Journal of Obstetrics, Gynecology, vol. 210, no. 2, pp. 125. e1-125. e15, 2014.
17. T. Myntti, L. Rahkonen, M. Tikkanen, J. Paavonen, V. Stefanovic, "Vaginally obtained amniotic fluid samples in the diagnosis of subclinical chorioamnionitis, " Acta Obstetricia et Gynecologica Scandinavica, vol. 95, no. 2, pp. 233-237, 2016.
18. T. Myntti, L. Rahkonen, A. Pätäri-Sampo, et al., "Comparison of amniotic fluid matrix metalloproteinase-8, cathelicidin in the diagnosis of intra-amniotic infection, " Journal of Perinatology, vol. 36, no. 12, pp. 1049-1054, 2016.
19. N. Hofer, E. Zacharias, W. Müller, B. Resch, "An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights, new tasks, " Neonatology, vol. 102, no. 1, pp. 25-36, 2012.
20. D. Garry, R. Figueroa, M. Aguero-Rosenfeld, E. Martinez, P. Visintainer, N. Tejani, "A comparison of rapid amniotic fluid markers in the prediction of microbial invasion of the uterine cavity, preterm delivery, " American Journal of Obstetrics, Gynecology, vol. 175, no. 5, pp. 1336-1341, 1996.
21. P. C. Greig, J. M. Ernest, L. Teot, "Low amniotic fluid glucose levels are a specific but not a sensitive marker for subclinical intrauterine infections in patients in preterm labor with intact membranes, " American Journal of Obstetrics, Gynecology, vol. 171, no. 2, pp. 365-371, 1994.
22. K. J. Oh, K. H. Park, S.-N. Kim, E. H. Jeong, S. Y. Lee, H. Y. Yoon, "Predictive value of intra-amniotic, serummarkers for inflammatory lesions of preterm placenta, " Placenta, vol. 32, no. 10, pp. 732-736, 2011.
23. T. Sorsa, L. Tjäderhane, Y. T. Konttinen, et al., "Matrix metalloproteinases: contribution to pathogenesis, diagnosis, treatment of periodontal inflammation, " Annals of Medicine, vol. 38, no. 5, pp. 306-321, 2006.
24. S. J. Fortunato, R. Menon, S. J. Lombardi, "MMP/TIMP imbalance in amniotic fluid during PROM: an indirect support for endogenous pathway to membrane rupture, " Journal of Perinatal Medicine, vol. 27, no. 5, pp. 362-368, 1999.
25. E. Maymon, R. Romero, P. Pacora, et al., "Evidence of in vivo differential bioavailability of the active forms of matrix metalloproteinases 9, 2 in parturition, spontaneous rupture of membranes, intra-amniotic infection, " American Journal of Obstetrics, Gynecology, vol. 183, no. 4, pp. 887-894, 2000.
26. S. A. Kim, K. H. Park, S. M. Lee, "Non-invasive prediction of histologic chorioamnionitis in women with preterm premature rupture of membranes, " Yonsei Medical Journal, vol. 57, no. 2, pp. 461-468, 2016.
27. R. Romero, N. Kadar, J. Miranda, et al., "The diagnostic performance of the Mass Restricted (MR) score in the identification of microbial invasion of the amniotic cavity or intra-amniotic inflammation is not superior to amniotic fluid interleukin-6, " Journal of Maternal-Fetal, Neonatal Medicine, vol. 27, no. 8, pp. 757-769, 2014.
28. B. R. Helmig, R. Romero, J. Espinoza, et al., "Neutrophil elastase, secretory leukocyte protease inhibitor in prelabor rupture of membranes, parturition, intra-amniotic infection, " Journal of Maternal-Fetal, Neonatal Medicine, vol. 12, no. 4, pp. 237-246, 2002.
29. G. J. Locksmith, P. Clark, P. Duff, G. R. Saade, G. S. Schultz, "Amniotic fluid concentrations of matrix metalloproteinase 9, tissue inhibitor of metalloproteinase 1 during pregnancy, labor, " American Journal of Obstetrics, Gynecology, vol. 184, no. 2, pp. 159-164, 2001.
30. N. Athayde, S. S. Edwin, R. Romero, et al., "A role for matrix metalloproteinase-9 in spontaneous rupture of the fetal membranes, " American Journal of Obstetrics, Gynecology, vol. 179, no. 5, pp. 1248-1253, 1998.
31. F. Ghezzi, M. Franchi, L. Raio, et al., "Elevated amniotic fluid C-reactive protein at the time of genetic amniocentesis is a marker for pretermdelivery, "American Journal ofObstetrics, Gynecology, vol. 186, no. 2, pp. 268-273, 2002.
32. M. oz, B. Polat, E. Ozgü, K. D. Seçkin, C. Taşin, N. Danişman, "Interleukin-6, C-reactive protein levels in the amniotic fluid as indicators of preterm delivery in Turkish women, " Clinical, Experimental Obstetrics, Gynecology, vol. 42, no. 6, pp. 801-804, 2015.
33. A. T. Dulay, I. A. Buhimschi, G. Zhao, et al., "Compartmentalization of acute phase reactants Interleukin-6, C-Reactive Protein, Procalcitonin as biomarkers of intra-amniotic infection, chorioamnionitis, " Cytokine, vol. 76, no. 2, pp. 236-243, 2015.
34. A. Malek, N. A. Bersinger, S. Di Santo, et al., "C-reactive protein production in term human placental tissue, " Placenta, vol. 27, no. 6-7, pp. 619-625, 2006.
35. B. H. Yoon, R. Romero, J.-Y. Shim, S.-S. Shim, C. J. Kim, J. K. Jun, "C-reactive protein in umbilical cord blood: a simple, widely available clinical method to assess the risk of amniotic fluid infection, funisitis, " Journal of Maternal-Fetal, Neonatal Medicine, vol. 14, no. 2, pp. 85-90, 2003.
36. J. Hitti, P. Tarczy-Hornoch, J. Murphy, S. L. Hillier, J. Aura, D. A. Eschenbach, "Amniotic fluid infection, cytokines, adverse outcome among infants at 34 weeks' gestation or less, " Obstetrics, Gynecology, vol. 98, no. 6, pp. 1080-1088, 2001.
37. Y. Maki, S. Furukawa, Y. Kodama, H. Sameshima, T. Ikenoue, "Amniocentesis for threatened preterm labor with intact membranes, the impact on adverse outcome in infants born at 22 to 28 weeks of gestation, " Early Human Development, vol. 91, no. 5, pp. 333-337, 2015.
38. R. P. Porreco, K. D. Heyborne, H. Shapiro, "Amniocentesis in the management of preterm premature rupture of the membranes: a retrospective cohort analysis, " Journal of Maternal-Fetal, Neonatal Medicine, vol. 21, no. 8, pp. 573-579, 2008.
39. K. L. Archabald, I. A. Buhimschi, M. O. Bahtiyar, et al., "Limiting the Exposure of select fetuses to intrauterine infection/inflammation improves short-term neonatal outcomes in pretermpremature rupture ofmembranes, " Fetal Diagnosis, Therapy, 12 pages, 2016.